Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization

Inclusion Criteria: * Enrollment in and completed the primary study through the Day 28 visit. * Received at least one dose of study drug in the primary study * Able to give written informed consent prior to completion of the primary study Exclusion Criteria: * Received systemic or topical vaginal non-study antifungal therapy at any time during the primary study * Diagnosed with bacterial vaginosis, trichomonas, gonorrhea, chlamydia, or active herpes at any point during the primary study * The Principal Investigator considers that the subject should not participate in the study